CMC Strategy Forum Japan

We are very pleased that with the strong support from the Pharmaceuticals and Medical Devices Agency (PMDA, Japan), as well as the Japan Pharmaceutical Manufacturers Association (JPMA), that we are continuing with the CMC Strategy Forum Japan 2021. In 2020, the series continued to be successful and included participation from nine regulatory agencies, thirteen countries and 38 companies and academic institutions, enabling an in-depth discussion of global CMC issues with special emphasis on Japan and Asia-Pacific. The Forum will follow the established model of the CMC Forum series with focus on topics and regulatory updates relevant for Japan and Asia Pacific and will take place virtually 6-8 December 2021. Each session will include live speaker presentations and panel discussions, and will last approximately 3.5 hours each day.